JAM-C has also been reported to act as a proangiogenic molecule, as its soluble form was demonstrated to induce in vitro angiogenesis [21], and its blockade was able to reduce tumor growth and decrease angiogenesis both in vivo and in vitro [47]. This evidence concerns the gene JAM3 and neoplasm.